PDE5 inhibitors promote recovery of peripheral neuropathy in diabetic mice.
作者信息
Wang Lei, Chopp Michael, Zhang Zheng Gang
机构信息
Department of Neurology, Henry Ford Hospital, Detroit, MI, USA.
Department of Neurology, Henry Ford Hospital, Detroit, MI, USA; Department of Physics, Oakland University, Rochester, MI, USA.
出版信息
Neural Regen Res. 2017 Feb;12(2):218-219. doi: 10.4103/1673-5374.200804.
Abstract
摘要
相似文献
1
PDE5 inhibitors promote recovery of peripheral neuropathy in diabetic mice.
Neural Regen Res. 2017 Feb;12(2):218-219. doi: 10.4103/1673-5374.200804.
2
PDE5 inhibitors in diabetic peripheral neuropathy.
Int J Clin Pract. 2006 Sep;60(9):1123-6. doi: 10.1111/j.1742-1241.2006.01087.x.
3
Nebivolol potentiates the efficacy of PDE5 inhibitors to relax corpus cavernosum and penile arteries from diabetic patients by enhancing the NO/cGMP pathway.
J Sex Med. 2014 May;11(5):1182-92. doi: 10.1111/jsm.12477.
4
TRPA1 sensitization during diabetic vascular impairment contributes to cold hypersensitivity in a mouse model of painful diabetic peripheral neuropathy.
Mol Pain. 2018 Jan-Dec;14:1744806918789812. doi: 10.1177/1744806918789812. Epub 2018 Jul 3.
5
Diabetic neuropathy after pancreas transplantation: determinants of recovery.
Transplantation. 1997 Mar 27;63(6):830-8. doi: 10.1097/00007890-199703270-00007.
6
Are phosphodiesterase type 5 inhibitors associated with vision-threatening adverse events? A critical analysis and review of the literature.
J Sex Med. 2011 Oct;8(10):2894-903. doi: 10.1111/j.1743-6109.2011.02382.x. Epub 2011 Jul 19.
7
Use of cGMP PDE5 inhibitors in the treatment of neuropathy: a review of the patent literature.
IDrugs. 2002 May;5(5):448-53.
8
Cardiovascular effects of phosphodiesterase type 5 inhibitors.
J Sex Med. 2009 Mar;6(3):658-74. doi: 10.1111/j.1743-6109.2008.01107.x. Epub 2008 Dec 2.
9
Impaired peripheral nerve regeneration in type-2 diabetic mouse model.
Eur J Neurosci. 2018 Jan;47(2):126-139. doi: 10.1111/ejn.13771. Epub 2018 Jan 11.
10
[Prevalence and risk factors of diabetic peripheral neuropathy in Chinese communities].
Zhonghua Liu Xing Bing Xue Za Zhi. 2019 Dec 10;40(12):1578-1584. doi: 10.3760/cma.j.issn.0254-6450.2019.12.014.
引用本文的文献
1
RNA Interference Unleashed: Current Perspective of Small Interfering RNA (siRNA) Therapeutics in the Treatment of Neuropathic Pain.
ACS Pharmacol Transl Sci. 2024 Sep 23;7(10):2951-2970. doi: 10.1021/acsptsci.4c00329. eCollection 2024 Oct 11.
2
Exploring the Multifaceted Potential of Sildenafil in Medicine.
Medicina (Kaunas). 2023 Dec 17;59(12):2190. doi: 10.3390/medicina59122190.
3
Sildenafil Enhances the Therapeutic Effect of Islet Transplantation for Diabetic Peripheral Neuropathy via mTOR/S6K1 Pathway.
Int J Endocrinol. 2023 Oct 7;2023:8199029. doi: 10.1155/2023/8199029. eCollection 2023.
4
The Influence of Sildenafil-Metformin Combination on Hyperalgesia and Biochemical Markers in Diabetic Neuropathy in Mice.
Medicina (Kaunas). 2023 Jul 27;59(8):1375. doi: 10.3390/medicina59081375.
5
Preparation, Optimization and Evaluation of Chitosan-Based Avanafil Nanocomplex Utilizing Antioxidants for Enhanced Neuroprotective Effect on PC12 Cells.
Gels. 2021 Jul 16;7(3):96. doi: 10.3390/gels7030096.
6
Diabetic neuropathy research: from mouse models to targets for treatment.
Neural Regen Res. 2019 Nov;14(11):1870-1879. doi: 10.4103/1673-5374.259603.
7
3-N-Butylphthalide mitigates high glucose-induced injury to Schwann cells: association with nitrosation and apoptosis.
Neural Regen Res. 2019 Mar;14(3):513-518. doi: 10.4103/1673-5374.245590.
8
Proanthocyanidin B2 attenuates high-glucose-induced neurotoxicity of dorsal root ganglion neurons through the PI3K/Akt signaling pathway.
Neural Regen Res. 2018 Sep;13(9):1628-1636. doi: 10.4103/1673-5374.237174.
9
Cardiac autonomic neuropathy: Risk factors, diagnosis and treatment.
World J Diabetes. 2018 Jan 15;9(1):1-24. doi: 10.4239/wjd.v9.i1.1.
10
Phosphodiesterase type 5 and cancers: progress and challenges.
Oncotarget. 2017 Oct 12;8(58):99179-99202. doi: 10.18632/oncotarget.21837. eCollection 2017 Nov 17.
本文引用的文献
1
Tadalafil Promotes the Recovery of Peripheral Neuropathy in Type II Diabetic Mice.
PLoS One. 2016 Jul 20;11(7):e0159665. doi: 10.1371/journal.pone.0159665. eCollection 2016.
2
Phosphodiesterase-5 Inhibitors: Action on the Signaling Pathways of Neuroinflammation, Neurodegeneration, and Cognition.
Mediators Inflamm. 2015;2015:940207. doi: 10.1155/2015/940207. Epub 2015 Dec 3.
3
Sildenafil ameliorates long term peripheral neuropathy in type II diabetic mice.
PLoS One. 2015 Feb 17;10(2):e0118134. doi: 10.1371/journal.pone.0118134. eCollection 2015.
4
Sildenafil attenuates inflammation and oxidative stress in pelvic ganglia neurons after bilateral cavernosal nerve damage.
Int J Mol Sci. 2014 Sep 26;15(10):17204-20. doi: 10.3390/ijms151017204.
5
The role of miR-146a in dorsal root ganglia neurons of experimental diabetic peripheral neuropathy.
Neuroscience. 2014 Feb 14;259:155-63. doi: 10.1016/j.neuroscience.2013.11.057. Epub 2013 Dec 6.
6
Phosphodiesterase-5 is a therapeutic target for peripheral neuropathy in diabetic mice.
Neuroscience. 2011 Oct 13;193:399-410. doi: 10.1016/j.neuroscience.2011.07.039. Epub 2011 Jul 27.
7
Comparison of the first intake of vardenafil and tadalafil in patients with diabetic neuropathy and diabetic erectile dysfunction.
J Sex Med. 2011 Mar;8(3):851-64. doi: 10.1111/j.1743-6109.2010.02148.x. Epub 2010 Dec 8.
8
Improvement of vascular function by acute and chronic treatment with the PDE-5 inhibitor sildenafil in experimental diabetes mellitus.
Br J Pharmacol. 2008 Mar;153(5):886-93. doi: 10.1038/sj.bjp.0707459. Epub 2007 Sep 24.
9
Advanced Diabetic Neuropathy: A Point of no Return?
Rev Diabet Stud. 2006 Fall;3(3):143-50. doi: 10.1900/RDS.2006.3.143. Epub 2006 Nov 10.
10
PDE5 inhibitors in diabetic peripheral neuropathy.
Int J Clin Pract. 2006 Sep;60(9):1123-6. doi: 10.1111/j.1742-1241.2006.01087.x.
Zotero 插件